CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma

Yunosuke Nishihara, Shinichi Aishima, Akifumi Hayashi, Tomohiro Iguchi, Nobuhiro Fujita, Akinobu Taketomi, Hiroshi Honda, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Aims: To identify the role of CD10 expression of tumour-associated fibroblastic cells in the progression of cholangiocarcinoma (CC). Methods and results: The CD10 expression of fibroblastic cells was investigated immunohistochemically in 167 cases of intrahepatic and extrahepatic CC and 29 cases of biliary dysplasia, comparing the clinicopathological parameters. CD10 expression of fibroblastic cells was observed in 5.7% (4/70) of peripheral intrahepatic CC, 29.2% (14/48) of hilar intrahepatic CC, and 57.1% (28/49) of extrahepatic CC. As for biliary dysplasia, CD10 expression of fibroblastic cells was observed in 4.3% (1/23) in the hepatic hilum and 20% (3/15) in the extrahepatic bile duct. CD10 expression had a strong relationship with the anatomical location of CC, and was more frequently detected in the periductal infiltrating type of hilar intrahepatic CC (P < 0.0001) and in less differentiated cases in extrahepatic CC (P = 0.0151). CD10 expression was observed more frequently in CC than in biliary dysplasia of hepatic hilum (P = 0.0365) and extrahepatic bile duct (P = 0.0262). CD10 expression was not a prognostic indicator in CC. Conclusions: We suggest that CD10+ fibroblasts are more involved in the progression of hilar and extrahepatic CC than of peripheral intrahepatic CC.

Original languageEnglish
Pages (from-to)423-431
Number of pages9
JournalHistopathology
Volume55
Issue number4
DOIs
Publication statusPublished - Oct 1 2009

Fingerprint

Klatskin Tumor
Cholangiocarcinoma
Fibroblasts
Extrahepatic Bile Ducts
Liver

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. / Nishihara, Yunosuke; Aishima, Shinichi; Hayashi, Akifumi; Iguchi, Tomohiro; Fujita, Nobuhiro; Taketomi, Akinobu; Honda, Hiroshi; Tsuneyoshi, Masazumi.

In: Histopathology, Vol. 55, No. 4, 01.10.2009, p. 423-431.

Research output: Contribution to journalArticle

Nishihara, Y, Aishima, S, Hayashi, A, Iguchi, T, Fujita, N, Taketomi, A, Honda, H & Tsuneyoshi, M 2009, 'CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma', Histopathology, vol. 55, no. 4, pp. 423-431. https://doi.org/10.1111/j.1365-2559.2009.03398.x
Nishihara, Yunosuke ; Aishima, Shinichi ; Hayashi, Akifumi ; Iguchi, Tomohiro ; Fujita, Nobuhiro ; Taketomi, Akinobu ; Honda, Hiroshi ; Tsuneyoshi, Masazumi. / CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. In: Histopathology. 2009 ; Vol. 55, No. 4. pp. 423-431.
@article{9f0335ffd4f94954a211e293533358a4,
title = "CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma",
abstract = "Aims: To identify the role of CD10 expression of tumour-associated fibroblastic cells in the progression of cholangiocarcinoma (CC). Methods and results: The CD10 expression of fibroblastic cells was investigated immunohistochemically in 167 cases of intrahepatic and extrahepatic CC and 29 cases of biliary dysplasia, comparing the clinicopathological parameters. CD10 expression of fibroblastic cells was observed in 5.7{\%} (4/70) of peripheral intrahepatic CC, 29.2{\%} (14/48) of hilar intrahepatic CC, and 57.1{\%} (28/49) of extrahepatic CC. As for biliary dysplasia, CD10 expression of fibroblastic cells was observed in 4.3{\%} (1/23) in the hepatic hilum and 20{\%} (3/15) in the extrahepatic bile duct. CD10 expression had a strong relationship with the anatomical location of CC, and was more frequently detected in the periductal infiltrating type of hilar intrahepatic CC (P < 0.0001) and in less differentiated cases in extrahepatic CC (P = 0.0151). CD10 expression was observed more frequently in CC than in biliary dysplasia of hepatic hilum (P = 0.0365) and extrahepatic bile duct (P = 0.0262). CD10 expression was not a prognostic indicator in CC. Conclusions: We suggest that CD10+ fibroblasts are more involved in the progression of hilar and extrahepatic CC than of peripheral intrahepatic CC.",
author = "Yunosuke Nishihara and Shinichi Aishima and Akifumi Hayashi and Tomohiro Iguchi and Nobuhiro Fujita and Akinobu Taketomi and Hiroshi Honda and Masazumi Tsuneyoshi",
year = "2009",
month = "10",
day = "1",
doi = "10.1111/j.1365-2559.2009.03398.x",
language = "English",
volume = "55",
pages = "423--431",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma

AU - Nishihara, Yunosuke

AU - Aishima, Shinichi

AU - Hayashi, Akifumi

AU - Iguchi, Tomohiro

AU - Fujita, Nobuhiro

AU - Taketomi, Akinobu

AU - Honda, Hiroshi

AU - Tsuneyoshi, Masazumi

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Aims: To identify the role of CD10 expression of tumour-associated fibroblastic cells in the progression of cholangiocarcinoma (CC). Methods and results: The CD10 expression of fibroblastic cells was investigated immunohistochemically in 167 cases of intrahepatic and extrahepatic CC and 29 cases of biliary dysplasia, comparing the clinicopathological parameters. CD10 expression of fibroblastic cells was observed in 5.7% (4/70) of peripheral intrahepatic CC, 29.2% (14/48) of hilar intrahepatic CC, and 57.1% (28/49) of extrahepatic CC. As for biliary dysplasia, CD10 expression of fibroblastic cells was observed in 4.3% (1/23) in the hepatic hilum and 20% (3/15) in the extrahepatic bile duct. CD10 expression had a strong relationship with the anatomical location of CC, and was more frequently detected in the periductal infiltrating type of hilar intrahepatic CC (P < 0.0001) and in less differentiated cases in extrahepatic CC (P = 0.0151). CD10 expression was observed more frequently in CC than in biliary dysplasia of hepatic hilum (P = 0.0365) and extrahepatic bile duct (P = 0.0262). CD10 expression was not a prognostic indicator in CC. Conclusions: We suggest that CD10+ fibroblasts are more involved in the progression of hilar and extrahepatic CC than of peripheral intrahepatic CC.

AB - Aims: To identify the role of CD10 expression of tumour-associated fibroblastic cells in the progression of cholangiocarcinoma (CC). Methods and results: The CD10 expression of fibroblastic cells was investigated immunohistochemically in 167 cases of intrahepatic and extrahepatic CC and 29 cases of biliary dysplasia, comparing the clinicopathological parameters. CD10 expression of fibroblastic cells was observed in 5.7% (4/70) of peripheral intrahepatic CC, 29.2% (14/48) of hilar intrahepatic CC, and 57.1% (28/49) of extrahepatic CC. As for biliary dysplasia, CD10 expression of fibroblastic cells was observed in 4.3% (1/23) in the hepatic hilum and 20% (3/15) in the extrahepatic bile duct. CD10 expression had a strong relationship with the anatomical location of CC, and was more frequently detected in the periductal infiltrating type of hilar intrahepatic CC (P < 0.0001) and in less differentiated cases in extrahepatic CC (P = 0.0151). CD10 expression was observed more frequently in CC than in biliary dysplasia of hepatic hilum (P = 0.0365) and extrahepatic bile duct (P = 0.0262). CD10 expression was not a prognostic indicator in CC. Conclusions: We suggest that CD10+ fibroblasts are more involved in the progression of hilar and extrahepatic CC than of peripheral intrahepatic CC.

UR - http://www.scopus.com/inward/record.url?scp=70349934740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349934740&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2009.03398.x

DO - 10.1111/j.1365-2559.2009.03398.x

M3 - Article

C2 - 19817893

AN - SCOPUS:70349934740

VL - 55

SP - 423

EP - 431

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 4

ER -